We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.96%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$771B
AUM Growth
+$65B
Cap. Flow
+$3.26B
Cap. Flow %
0.42%
Top 10 Hldgs %
21.76%
Holding
2,605
New
87
Increased
1,561
Reduced
802
Closed
81

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$6.97B
2
AMD icon
Advanced Micro Devices
AMD
+$1.37B
3
LULU icon
lululemon athletica
LULU
+$1.32B
4
SPOT icon
Spotify
SPOT
+$1.28B
5
NOW icon
ServiceNow
NOW
+$1.25B

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$3.41B
2
NOC icon
Northrop Grumman
NOC
+$2.36B
3
MSFT icon
Microsoft
MSFT
+$2.2B
4
MCD icon
McDonald's
MCD
+$1.85B
5
ICE icon
Intercontinental Exchange
ICE
+$1.28B

Sector Composition

Rank Sector Weight
1 Technology 21.34%
2 Healthcare 16.78%
3 Financials 13.77%
4 Consumer Discretionary 12.98%
5 Communication Services 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1226
iShares Core S&P 500 ETF
IVV
$910B
$16.6M ﹤0.01%
51,483
-8,566
-14% -$2.65M
SRRK icon
1227
Scholar Rock
SRRK
$6.55B
$16.6M ﹤0.01%
1,257,531
-16,336
-1% -$157K
BWA icon
1228
BorgWarner
BWA
$14B
$16.5M ﹤0.01%
432,422
-3,074
-0.7% -$113K
KIM icon
1229
Kimco Realty
KIM
$16.2B
$16.5M ﹤0.01%
797,352
+30,133
+4% +$632K
HZN
1230
DELISTED
Horizon Global Corporation
HZN
$16.4M ﹤0.01%
4,697,027
+474,537
+11% +$1.76M
ARMK icon
1231
Aramark
ARMK
$16.1B
$16.3M ﹤0.01%
520,768
+5,398
+1% +$169K
LL
1232
DELISTED
LL Flooring Holdings, Inc.
LL
$16.1M ﹤0.01%
1,648,420
+10,952
+0.7% +$102K
ZION icon
1233
Zions Bancorporation
ZION
$10.5B
$16.1M ﹤0.01%
310,169
-19,501
-6% -$947K
NX icon
1234
Quanex
NX
$1B
$16M ﹤0.01%
938,675
-1,114,602
-54% -$21M
ZLAB icon
1235
Zai Lab
ZLAB
$2.86B
$15.9M ﹤0.01%
382,699
-95,222
-20% -$3.52M
FFIV icon
1236
F5
FFIV
$24B
$15.6M ﹤0.01%
111,714
+3,525
+3% +$497K
IRWD icon
1237
Ironwood Pharmaceuticals
IRWD
$714M
$15.5M ﹤0.01%
1,166,815
-4,067
-0.3% -$44.8K
AIV
1238
Aimco
AIV
$379M
$15.3M ﹤0.01%
2,226,308
+21,905
+1% +$155K
TNDM icon
1239
Tandem Diabetes Care
TNDM
$1.63B
$15.3M ﹤0.01%
256,835
-34,582
-12% -$2.13M
BILL icon
1240
BILL Holdings
BILL
$4.85B
$15.3M ﹤0.01%
+400,977
New +$15.2M
SABR icon
1241
Sabre
SABR
$831M
$15.2M ﹤0.01%
679,085
-26,396
-4% -$585K
SFIX
1242
Stitch Fix
SFIX
$487M
$15M ﹤0.01%
583,789
-216,654
-27% -$5.03M
RGCO icon
1243
RGC Resources
RGCO
$225M
$14.9M ﹤0.01%
520,921
+8,080
+2% +$234K
AXTA icon
1244
Axalta
AXTA
$7.93B
$14.8M ﹤0.01%
486,039
-19,404
-4% -$572K
CYRX icon
1245
CryoPort
CYRX
$766M
$14.7M ﹤0.01%
891,786
+188,600
+27% +$2.81M
PAHC icon
1246
Phibro Animal Health
PAHC
$1.37B
$14.7M ﹤0.01%
590,998
-23,091
-4% -$536K
BZUN
1247
Baozun
BZUN
$164M
$14.6M ﹤0.01%
441,400
-965,104
-69% -$38.3M
ADVM
1248
DELISTED
Adverum Biotechnologies
ADVM
$14.4M ﹤0.01%
125,179
+20,569
+20% +$1.81M
NWL icon
1249
Newell Brands
NWL
$2.62B
$14.3M ﹤0.01%
743,693
-14,170
-2% -$273K
ICHR icon
1250
Ichor Holdings
ICHR
$2.59B
$14.3M ﹤0.01%
428,914
-4,591
-1% -$137K

Similar funds

T. Rowe Price Associates's Q4 2019 Portfolio in Review

As of Q4 2019, T. Rowe Price Associates held 2,605 positions worth $771B, up 9.2% from $706B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

T. Rowe Price Associates's Q4 2019 filing shows 87 new, 1,561 increased, 802 reduced and 81 closed positions. Its largest new stake was XP: 7,905,172 shares worth $305M. The largest sale was Boeing, an estimated $3.41B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2019 buy was XP: 7,905,172 shares worth $305M.
  • T. Rowe Price Associates added most to Apple in Q4 2019, an estimated $6.97B increase.
  • T. Rowe Price Associates's biggest Q4 2019 reduction was Boeing, cutting an estimated $3.41B.
  • T. Rowe Price Associates fully exited Viacom Inc. Class B in Q4 2019, selling an estimated $204M.
  • T. Rowe Price Associates's ten largest holdings make up 22% of its $771B portfolio in Q4 2019.
  • T. Rowe Price Associates opened 87 new positions and closed 81 in Q4 2019.
  • T. Rowe Price Associates's portfolio value rose 9.2% quarter-over-quarter to $771B.

Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.